3 completed, 1 enrolling by invitation, 1 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Enrolling by invitation 1, Unknown 1 |
Follow Benicar: new trials by email Literature Review of Benicar trials Research Report on Benicar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT) Olmesartan medoxomil tablets, Antihypertensive medication (per doctor suggestion) - Coronary Atherosclerosis | Phase 4 | Unknown | Chinese PLA General Hospital | 100 | 2014-12-01 | 2015-02-11 |
| Olmesartan Comparison to Losartan in Hypertensive Subjects olmesartan medoxomil, Placebo, losartan potassium - Hypertension | Phase 4 | Completed | Daiichi Sankyo | 941 | 2009-08-01 | 2011-03-09 |
| Drug Interaction Study of Olmesartan in Healthy Chinese Volunteers olmesartan medoxomil, olmesartan medoxomil+probenecid - Drug Interaction of Olmesartan in Healthy Chinese Volunteers | Phase 4 | Completed | Central South University | 12 | 2009-08-01 | 2013-07-25 |
| Angiotensin II Blockade and Inflammation in Obesity Olmesartan medoxomil - Overweight, Obese | Phase 4 | Completed | Virginia Polytechnic Institute and State University | 20 | 2009-02-01 | 2018-01-03 |
Hypertension (2) · Albuminuria (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Hyperkalemia (1) · Obesity (1) · Overweight (1) · Prehypertension (1) · Renal Insufficiency, Chronic (1)
Baylor Research Institute (1) · Central South University (1) · Chinese PLA General Hospital (1) · Daiichi Sankyo (1) · Virginia Polytechnic Institute and State University (1)
China (2) · United States (2)
Chen Yundai (1) · Kevin P. Davy, Ph.D. (1) · Kunyan Li, phD (1) · Nong Yang, MS (1)